Editas Medicine Inc
EDIT
Market Cap$190.87M
Close$
$-1.27
157.6% downside
Current Fair Value
157.6% downsideOvervalued by 157.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $190.87 Million |
|---|---|
| Enterprise Value | $90.77 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.88 |
| Beta | 2.1 |
| Outstanding Shares | 83,055,066 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.75 |
|---|---|
| PEG | -3.3 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.91 |
| Enterprise Value to EBIT | -0.5 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.43 |
| Debt to Equity | 0.62 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Editas Medicine Inc
CEO: Cynthia Collins